Skip to main content

Table 1 Clinical, biochemical, and angiographic characteristics of study subjects in different groups

From: Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years

 

Total

MACCE

p value

Negative (n = 402)

Positive (n = 177)

Age (years old)

72.10 ± 5.18

72.13 ± 5.16

72.03 ± 5.24

0.978

Male/Female

360/210

281/121

127/50

0.653

BMI (kg/m2)

25.11 ± 2.98

25.15 ± 2.96

25.03 ± 3.03

0.913

Smoking, n (%)

318/579 (54.9)

220/402 (54.7)

98/177 (55.3)

0.886

Hypertension, n (%)

375/579 (64.8)

262/402 (65.2)

113/177 (64.8)

0.757

Dyslipidemia (%)

510/579 (88.1)

355/402 (87.8)

157/177 (88.7)

0.892

Anti-hypertensive therapy, n (%)

340/579 (58.7)

248/402 (61.7)

92/177 (52.0)

0.029

Lipid-lowering therapy, n (%)

377/579 (65.1)

272/402 (67.7)

105/177 (59.3)

0.028

SBP (mmHg)

134 ± 17

134 ± 17

132 ± 16

0.613

DBP (mmHg)

80 ± 16

77 ± 17

81 ± 15

0.982

FPG (mg/dl)

125.60 ± 17.67

124.50 ± 16.93

127.70 ± 19.11

0.141

HbA1c (%)

6.48 ± 1.57

6.30 ± 1.60

6.89 ± 1.40

0.001

Insulin (mU/L)

12.15 ± 3.37

12.06 ± 3.35

12.38 ± 3.42

0.572

TG (mg/dl)

125.70 ± 43.03

125.2 ± 44.19

126.90 ± 40.26

0.911

TC (mg/dl)

218.10 ± 51.17

217.80 ± 50.38

218.80 ± 53.06

0.978

HDL-C (mg/dl)

43.10 ± 10.24

43.31 ± 10.13

42.62 ± 10.50

0.755

LDL-C (mg/dl)

117.10 ± 39.65

114.30 ± 43.51

123.40 ± 28.14

0.037

sdlDL-C (mg/dl)

30.07 ± 10.58

27.09 ± 9.21

36.84 ± 10.40

0.001

ApoA-I (mg/dl)

130.90 ± 20.22

132.70 ± 21.29

126.90 ± 16.94

0.006

ApoB (mg/dl)

93.06 ± 17.38

91.47 ± 17.56

96.64 ± 16.47

0.004

Lp (a) (mg/dl)

22.26 ± 14.33

21.83 ± 14.73

23.25 ± 13.35

0.544

hsCRP (mg/L)

6.91 ± 3.18

6.89 ± 3.12

6.96 ± 3.34

0.972

Neutrophils (× 109 /L)

3.63 ± 1.03

3.65 ± 0.95

3.57 ± 1.20

0.768

Scr (µmol/L)

76.41 ± 31.04

75.82 ± 27.95

77.74 ± 37.16

0.789

UA (µmol/L)

266.50 ± 89.45

265.50 ± 90.32

268.70 ± 87.63

0.922

NGAL (ug/L)

128.4 ± 70.55

106.4 ± 49.81

178.4 ± 84.09

0.001

  1. Variables with p value < 0.05 were identifed as signifcant variables and they are in bold
  2. N number of patients, BMI Body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FPG Fasting plasma glucose, HbA1c glycated hemoglobin A1c, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein-C, LDL-C low-density lipoprotein, sdlDL-C small low-density lipoprotein, ApoA-I Apolipoprotein A–I, ApoB Apolipoprotein B, Lp(a) lipoprotein a, hsCRP high-sensitivity CRP, neutrophils number of neutrophils, Scr serum creatinine, UA uric acid, NGAL neutrophil gelatinase-associated lipocalin
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840